Substrate specificities of 5′-deoxy-5′-methylthioadenosine phosphorylase from Trypanosoma brucei brucei and mammalian cells

The separation by chromatofocusing of two distinct purine nucleoside cleaving activities from crude extracts of Trypanosoma brucei brucei is described. One catalyzes the reversible phosphorolysis of 5′-deoxy-5′-methylthioadenosine (MeSAdo) and adenosine (Ado) and was designated an MeSAdo/Ado phospho...

Full description

Saved in:
Bibliographic Details
Published inMolecular and biochemical parasitology Vol. 27; no. 2; pp. 109 - 118
Main Authors Ghoda, Lucy Y., Savarese, Todd M., Northup, Catherine H., Parks, Robert E., Garofalo, Joanne, Katz, Libby, Ellenbogen, Barbara B., Bacchi, Cyrus J.
Format Journal Article
LanguageEnglish
Published Shannon Elsevier B.V 15.01.1988
Elsevier Science
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The separation by chromatofocusing of two distinct purine nucleoside cleaving activities from crude extracts of Trypanosoma brucei brucei is described. One catalyzes the reversible phosphorolysis of 5′-deoxy-5′-methylthioadenosine (MeSAdo) and adenosine (Ado) and was designated an MeSAdo/Ado phosphorylase, while the other catalyzes the hydrolysis of adenosine, inosine, and guanosine but not MeSAdo. The substrate specificity of trypanosomal MeSAdo/Ado phosphorylase differed from that of a mammalian MeSAdo phosphorylase (derived from murine Sarcoma 180 cells) in that it was able to phosphorolyze 2′-deoxyadenosine, 3′-deoxyadenosine and 2′,3′-dideoxyadenosine. In addition, the trypanosomal phosphorylase was able to utilize the nucleoside analog, 6-methylpurine 2′-deoxyribonucleoside, as an alternative substrate, whereas the mammalian enzyme could not. Because of these differences, cytotoxic analogs of MeSAdo may be designed that are selectively activated by the trypanosomal MeSAdo/Ado phosphorylase.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0166-6851
1872-9428
DOI:10.1016/0166-6851(88)90030-8